Page last updated: 2024-08-21

benzoxazoles and dactolisib

benzoxazoles has been researched along with dactolisib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, M; Kakiuchi, Y; Kakutani, K; Kanda, Y; Kuroda, R; Miyazaki, S; Nishida, K; Takada, T; Takeoka, Y; Yurube, T1
Divé, I; Heinzen, D; Lorenz, NI; Luger, AL; Ronellenfitsch, MW; Steinbach, JP1

Other Studies

2 other study(ies) available for benzoxazoles and dactolisib

ArticleYear
Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction.
    Osteoarthritis and cartilage, 2019, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Autophagy; Benzoxazoles; beta-Galactosidase; Cellular Senescence; Curcumin; Everolimus; Extracellular Matrix; Female; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Inflammation; Male; Matrix Metalloproteinases; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Microtubule-Associated Proteins; Middle Aged; Nucleus Pulposus; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Quinolines; Ribosomal Protein S6 Kinases, 70-kDa; Sequestosome-1 Protein; Sirolimus

2019
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment.
    International journal of molecular sciences, 2019, Sep-10, Volume: 20, Issue:18

    Topics: Apoptosis; Benzoxazoles; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Imidazoles; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Naphthyridines; Protein Kinase Inhibitors; Pyrimidines; Quinolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2019